u/News_9692

Been looking at a few small companies working on different delivery approaches for tough neurological conditions. One of them just hit a notable clinical milestone with their lead asset and should have more updates soon.

Still very early and high risk, but the method they’re using stands out compared to the usual approaches in this space.Curious if anyone else is tracking small biotechs with novel delivery tech or unique mechanisms at the moment.

https://preview.redd.it/z6uebqxj81fh1.png?width=1294&format=png&auto=webp&s=6585fb359c999ec0f086df2a28b47373e4d17935

Anthropic: “We care deeply about the safety of humanity”

Also Anthropic: “Please make everyone pay a little extra so we can stay rich”

Calling it the “Dario tax” is actually genius. Protectionism has never sounded so ethical.

FDA needs to wake up and prioritize patients like real leaders should. For rare diseases, adcomms must include the fighters who live it. They know the brutal trade offs and the clock ticking. FDA should stop gatekeeping with perfect data, get patients in the room and deliver results faster.

"The number of new firms projected within 12 months is 24% higher than a year ago in some sectors

While it may still spawn a jobs apocalypse, artificial intelligence is set to spark a record number of new entrepreneurs in the US.

Many of these startups could fail quickly, as AI helps dubious business plans move forward — a new wrinkle on the “AI slop” that’s all over social media. But the AI-enabled startup surge is so robust it should yield many lasting companies even after the weaker ones peter out, said Aaron Terrazas, an economist who works with small business services firm Gusto."